NIP
DTIL icon

Nicholas Investment Partners’s Precision BioSciences DTIL Stock Holding History

Nicholas Investment Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,326
Closed -$527K – 206
2019
Q2 		$527K Buy
1,326
+602
+83% +$242K 0.05% 203
2019
Q1 		$390K Buy
+724
New +$384K 0.03% 207

Other funds holding DTIL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nicholas Investment Partners's DTIL Position: Q3 2019 in Review

Nicholas Investment Partners sold out of Precision BioSciences (DTIL) in Q3 2019, closing a stake of 1,326 shares — an estimated $527K sold.

Nicholas Investment Partners first reported a position in DTIL in Q1 2019 and held it in 2 quarters. The position peaked at $527K in Q2 2019. 72 funds tracked by Wall St. Rank hold DTIL as of Q3 2019.

  • Nicholas Investment Partners reported no remaining Precision BioSciences position as of Q3 2019 after selling out during the quarter.
  • Nicholas Investment Partners sold 1,326 Precision BioSciences shares in Q3 2019, an estimated $527K.
  • Nicholas Investment Partners first reported a position in Precision BioSciences in Q1 2019 and held it in 2 quarters.
  • Nicholas Investment Partners's Precision BioSciences position peaked at $527K in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2019.

Based on Nicholas Investment Partners's 13F filing for Q3 2019, filed 13 Nov 2019.